By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IMPAX Laboratories 

30831 Huntwood Avenue

Hayward  California  94544  U.S.A.
Phone: 510-476-2000 Fax: 510-471-3200



Drug Delivery

Company News
IMPAX Labs (IPXL) Receives Positive CHMP Opinion for NUMIENT (Levodopa And Carbidopa) Modified-Release Capsules For The Symptomatic Treatment Of Adult Patients With Parkinson's Disease 9/28/2015 6:04:16 AM
IMPAX Labs (IPXL) Receives FDA Approval For Generic Version Of Testred C-III (Methyltestosterone Capsules, USP), 10 Mg 9/22/2015 11:18:53 AM
IMPAX Labs (IPXL) Receives FDA Approval For Generic Version Of Mestinon Timespan Tablets, 180 Mg 9/17/2015 6:27:17 AM
IMPAX Labs (IPXL) To Present At The Morgan Stanley (MST) Global Healthcare Conference 9/11/2015 9:35:31 AM
IMPAX Labs (IPXL) Announces Resolution Of FDA Warning Letter Related To Its Hayward Manufacturing Facility 9/8/2015 6:53:57 AM
IMPAX Labs (IPXL) Reports Second Quarter 2015 Financial Results 8/10/2015 9:01:35 AM
IMPAX Labs (IPXL) Unloads Daraprim to Turing Pharma in $55 Million Deal 8/10/2015 6:17:26 AM
IMPAX Labs (IPXL) Announces Sale Of Daraprim To Turing Pharmaceuticals 8/10/2015 6:17:22 AM
IMPAX Labs (IPXL) To Report Second Quarter 2015 Results On August 10, 2015 7/7/2015 7:27:41 AM
IMPAX Labs (IPXL) Founder and Ex-CEO Resigns Board Seat 7/7/2015 6:19:26 AM